Family Planning Curriculum
|
|
|
- Cecily Harmon
- 10 years ago
- Views:
Transcription
1 Family Planning Curriculum University of Alabama at Birmingham Department of Obstetrics and Gynecology
2 Module 1: Introduction Incidence of unintended pregnancy and abortion Safety of abortion, morbidity and mortality Abortion access and restrictions to abortion Abortion and contraception decision-making Introductory 1. Reason U.S. Women Have Abortions: Quantitative and Qualitative Perspectives. Finer et al, Perspectives on Sexual and Reproductive Health Sept;37(3): An Overview of Abortion in the United States. Guttmacher Institute, October 2009; html 3. Facts on Induced Abortion in the United States. Guttmacher Institute, July 2008; Module 2: Surgical Abortion Characteristics and protocol of early abortion methods (Medication vs. Aspiration abortion) Principles of surgical technique Pre-procedure preparation, including cervical preparation Setup and equipment: room setup, instruments and supplies, ultrasound Pain control, including anesthesia/analgesia protocol Post-procedure care First-Trimester 1. Chapter 10: First-trimester aspiration abortion. Meckstroth K and Paul M. In: Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD. Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. Oxford, UK: Blackwell Publishing Ltd; 2009: Early Surgical Abortion: An alternative to and backup for medical abortion. MacIsaac et al, American Journal of Obstetrics and Gynecology Aug;183(2):S Second-Trimester 1. Chapter 11: Dilation and evacuation. Hammond C and Chasen S. In: Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD. Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. Oxford, UK: Blackwell Publishing Ltd; 2009:
3 Module 3: Medication Abortion and Labor Induction Understanding medication abortion agents (mifepristone, methotrexate, misoprostol): pharmacokinetics, efficacy and cost Medication abortion regimens and protocol Techniques for induction abortion Patient eligibility, counseling, preparation, pain management, side effects and complications for medication abortion and induction Post-procedure care and contraception 1. Chapter 9: Medical abortion in early pregnancy. Creinin MD and Danielsson KG. In: Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD. Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. Oxford, UK: Blackwell Publishing Ltd; 2009: Chapter 12: Medical methods to induce abortion in the second trimester. Kapp N and von Hertzen H. In: Paul M, Lichtenberg ES, Borgatta L, Grimes DA, Stubblefield PG, Creinin MD. Management of Unintended and Abnormal Pregnancy: Comprehensive Abortion Care. Oxford, UK: Blackwell Publishing Ltd; 2009: NAF Protocol for Mifepristone/Misoprostol in Early Abortion. National Abortion Federation, January dical_abortion/protocol_mife_miso.pdf Module 4: Miscarriage Management Management of first- and second-trimester pregnancy loss: surgical, expectant and medical management Safety and effectiveness of treatment for early pregnancy loss (anembryonic pregnancy, embryonic demise, fetal demise, incomplete miscarriage, inevitable miscarriage) 1. Medical management of early pregnancy failure: efficacy. Chen B and Creinin MD, Seminars in Reproductive Medicine Sep;26(5): Expectant care versus surgical treatment for miscarriage. Nanada K. et al, Cochrane Database of Systematic Reviews Apr 19;(2).
4 Module 5: Contraception Contraceptive efficacy, medical eligibility criteria, and contraindications to the use of contraceptives. Mechanisms of action of contraception. Contraceptive counseling, including post-partum and post-abortion contraception. Overview 1. Contraceptive Efficacy. Hatcher RA, Trussell J et al. Contraceptive Technology: Nineteenth Revised Edition. New York NY: Ardent Media, Available at 2. Pearl Index. Speroff et al, A Clinical Guide for Contraception. 2005:4 3. Hormonal Contraception. Blumenthal et al, Obstetrics and Gynecology Sept;112(3): Summary Chart of the U.S. Medical Eligibility Criteria for Contraceptive Use. Centers for Disease Control, March Available at: Combined Hormonal Contraception 1. Oral Contraception. Speroff et al, Clinical Guide for Contraception. 2005: Vaginal and Transdermal Combined Contraception. Speroff et al, Clinical Guide for Contraception. 2005: Progestin-Only 1. WHO Statement on hormonal contraception and bone health. World Health Organization, July Available at Non-Hormonal & IUC 1. Intrauterine and Barrier Contraception. A practical review of recent developments. Masters et al, Current Obstetrics and Gynecology. Feb 2005;15(1): Intrauterine Device. ACOG Practice Bulletin Jan;105(1): Use of Copper Intrauterine Devices and the Risk of Tubal Infertility Among Nulligravid Women. Hubacher et al, New England Journal of Medicine Aug;345(8): Benefits and Risks of Sterilization. Pollack. ACOG Practice Bulletin Sept;102(3):647-58
5 5. Ambulatory Gynaecological Surgery: Transcervical Sterilization. Abbot et al, Best Practice & Research Clinical Obstetrics & Gynecology. Oct 2005; 19(5): Contraception in the Postpartum Period 1. IMAP Statement on postpartum contraception and breast-feeding. IPPF Medical Bulletin Sept;42(3):1-5. Available at: Emergency Contraception 1. Emergency Contraception. ACOG Practice Bulletin Dec;106(6):
Frequently Asked Questions
Frequently Asked Questions What is Medabon? Medabon is a combination therapy for medical abortion. Medical abortion refers to the process of ending a pregnancy by taking medication, rather than through
THE DIFFERENCE BETWEEN THE MORNING-AFTER PILL AND THE ABORTION PILL
THE DIFFERENCE BETWEEN THE MORNING-AFTER PILL AND There has been considerable public confusion about the difference between the morning-after pill and the abortion pill because of misinformation disseminated
IMAP Statement on Safe Abortion
International Planned Parenthood Federation IMAP Statement on Safe Abortion Key points: When performed early in pregnancy by trained health personnel in adequate facilities, abortion is a very safe procedure
Q: Who has abortions? Q: Who has abortions?
Q: Who has abortions? Q: Who has abortions? 1 A: Women who have abortions come from all racial, ethnic, socioeconomic, and religious backgrounds. Most abortions occur among women who are 20-24, low-income,
Clinical Interruption of Pregnancy (Medical/Surgical Abortion)
Clinical Interruption of Pregnancy (Medical/Surgical Abortion) Approximately one fifth of all pregnancies in the United States end in abortion (Ventura et al., 2009). According to the CDC (2011a), there
Keywords: Efficacy, Misoprostol Vaginal Administration, Pregnancy
A COMPARISON OF EFFICACY AND SIDE-EFFECTS OF TWO METHODS OF VAGINAL MISOPROSTOL ADMINISTRATION IN THE FIRST TRIMESTER OF PREGNANCY TERMINATION FOR PATIENTS OF BANDARABAS HOSPITAL LOCATED IN IRAN *Azadeaskari,
Safe abortion: technical and policy guidance for health systems. Second edition
Safe abortion: technical and policy guidance for health systems Second edition Safe abortion: technical and policy guidance for health systems Second edition Acknowledgements WHO is grateful for the technical
Alternatives to mifepristone for early medical abortion
International Journal of Gynecology and Obstetrics (2007) 96, 212 218 available at www.sciencedirect.com www.elsevier.com/locate/ijgo SPECIAL ARTICLE Alternatives to mifepristone for early medical abortion
Facts for Women Termination of pregnancy, abortion, or miscarriage management
Patient Education Facts for Women Termination of pregnancy, abortion, or miscarriage management This handout answers common questions about miscarriage management and the termination of a pregnancy, also
An Overview of Abortion in the United States. Guttmacher Institute January 2014
An Overview of Abortion in the United States Guttmacher Institute January 2014 Objectives Provide an overview of unintended pregnancy and abortion in the United States. Review the incidence of pregnancy
BACKGROUNDER CONTRACEPTION
BACKGROUNDER CONTRACEPTION DID YOU KNOW?» Approximately 85 out of 100 sexually active women who are not using any contraceptive method will get pregnant within one year. 1» Worldwide 38% of women who become
Contraceptive Choice & Reducing Unplanned Pregnancy. Dr Paula Briggs Consultant in Sexual & Reproductive Health, UK
Contraceptive Choice & Reducing Unplanned Pregnancy Dr Paula Briggs Consultant in Sexual & Reproductive Health, UK Demographics Liverpool, UK Conflicts Dr Paula Briggs has received funding from: MSD Bayer
Young Women and Long-Acting Reversible Contraception. Safe, Reliable, and Cost-Effective Birth Control
ISSUES AT A GLANCE Young Women and Long-Acting Reversible Contraception Safe, Reliable, and Cost-Effective Birth Control In 2012, the American College of Obstetricians and Gynecologists (ACOG) revised
Insurance Reimbursement for Post-Pregnancy Long-Acting Reversible Contraception (LARC) Background Benefits of LARC
Insurance Reimbursement for Post-Pregnancy Long-Acting Reversible Contraception (LARC) Shandhini Raidoo MD, Bliss Kaneshiro MD, MPH, Mary Tschann MPH, Reni Soon MD, MPH, Emmakate Friedlander MD, Jennifer
Induced Abortion. Dr. Anan Sacdpraseuth Mahosot Hospital
Induced Abortion Dr. Anan Sacdpraseuth Mahosot Hospital GFMER - WHO - UNFPA - LAO PDR Training Course in Reproductive Health Research Vientiane, 26 November 2009 Induced Abortion Introduction 40 to 60
Saving women s lives: the health impact of unsafe abortion
Saving women s lives: the health impact of unsafe abortion - worldwide and in emergency settings SRHR in Emergencies: from policy commitment to implementation, DGD, Brussels, 18 October 2012 Thérèse Delvaux,
Frequently Asked Questions (FAQ) for Medical Abortion
Frequently Asked Questions (FAQ) for Medical Abortion 1. What is medical abortion (MA)? MA is the use of one or more medications to terminate or end a pregnancy. Medical abortion is most effective when
Drug-Induced or Medical Abortion
Chapter 8 Drug-Induced or Medical Abortion Since 1985, when the drug RU-486 was introduced by the French pharmaceutical company, Roussel-Uclef, women have had an alternative to surgical abortion. RU-486
Safe & Unsafe. abortion
Safe & Unsafe Facts About abortion WHAT IS THE DIFFERENCE BETWEEN UNSAFE AND SAFE ABORTION? What is unsafe abortion? Unsafe abortion is a procedure for terminating an unplanned pregnancy either by a person
Each year more than 75 million women worldwide experience an unintended
Inside Pregnancy Diagnostics... 7 OUT Feature Article New Approaches to Early Abortion Each year more than 75 million women worldwide experience an unintended pregnancy. 1 For many of these women, contraception
Information for you Abortion care
Information for you Abortion care Published in February 2012 This information is for you if you are considering having an abortion. It tells you: how you can access abortion services the care you can expect
6.1 Contraceptive Knowledge and Practices of Women Requesting Medical Termination of Pregnancy
6. UNSAFE ABORTIONS Complications from unsafe abortions if untreated, could lead to morbidity or death. The best way to prevent unsafe abortions is to reduce the unmet need for contraception and make safe
A Quick Reference Guide for Clinicians
A Quick Reference Guide for Clinicians Association of Reproductive Health Professionals This Quick Reference Guide for Clinicians presents a summary of scientific information about manual vacuum aspiration
FEATURE. Adolescent Girls and Abortion
Adolescent Girls and Abortion Lawren Wellisch, MD; and Julie Chor, MD, MPH Abstract Abortion is an extremely common procedure in the United States, with approximately 2% of women having an abortion before
PROTOCOL RECOMMENDATIONS FOR USE OF METHOTREXATE AND MISOPROSTOL IN EARLY ABORTION
PROTOCOL RECOMMENDATIONS FOR USE OF METHOTREXATE AND MISOPROSTOL IN EARLY ABORTION INTRODUCTION: Both methotrexate and misoprostol have been approved by the U.S. Food and Drug Administration (FDA) for
NEW YORK STATE Department of Health
1 NEW YORK STATE Department of Health MEDICAID FEE-FOR-SERVICE BILLING FOR FAMILY PLANNING WEBINAR JUNE 20, 2014 To view recorded webinar, go to: https://www3.gotomeeting.com/register/241775910 2 Welcome
Advocacy for Safe Abortion Access
PATHFINDER INTERNATIONAL abortion policy scan for advocacy objectives This tool is intended to help organizations: Assess the legal context for abortion. Assess the actual/on-the-ground context for abortion.
Effective long-lasting strategy to prevent unintended pregnancy. The intrauterine system for contraception after abortion.
Effective long-lasting strategy to prevent unintended pregnancy. The intrauterine system for contraception after abortion. After the abortion I started re-thinking my birth control method. I am looking
OB/GYN. Clerkship Learning Objectives. Office for Clinical Affairs Department of OB/GYN (515) 271-1629 (515) 271-1421 FAX (515) 271-1727
OB/GYN Clerkship Learning Objectives Rebecca Shaw, MD, FACOG Office for Clinical Affairs Department of OB/GYN (515) 271-1629 (515) 271-1421 FAX (515) 271-1727 General Description Required Rotation This
Nowrosjee Wadia Maternity Hospital
6. UNSAFE ABORTIONS The family planning programme of India is targeting towards providing a wide range of contraceptive choices to eligible couples with the ultimate objective of decreasing the unwanted
Management of Unintended and Abnormal Pregnancy
Management of Unintended and Abnormal Pregnancy Comprehensive Abortion Care Edited by Maureen Paul, MD, MPH E. Steve Lichtenberg, MD, MPH Lynn Borgatta, MD, MPH David A. Grimes, MD Phillip G. Stubblefield,
Early Pregnancy Assessment Unit EPAU
Early Pregnancy Assessment Unit EPAU Introduction Miscarriage occurs in 20 30% of clinical pregnancies and accounts for 55,000 couples experiencing early pregnancy loss each year in Australia. With the
Chapter 10. When Abortion Fails
Chapter 10 When Abortion Fails Occasionally abortion fails, especially when it is drug induced. When this happens, either a second D&C or a more serious surgery may be attempted. The other alternative
New approaches to management of early pregnancy loss (miscarriage) Larry Leeman MD MPH UNM MCH Resident School September 5, 2012
New approaches to management of early pregnancy loss (miscarriage) Larry Leeman MD MPH UNM MCH Resident School September 5, 2012 Disclosure Statement No conflicts of interest Misoprostol is not FDA approved
Preventing unsafe abortion
Preventing unsafe abortion Fact sheet N 388 March 2014 Key facts Around 22 million unsafe abortions are estimated to take place worldwide each year, almost all in developing countries. Deaths due to unsafe
IUD training principles 2013
IUD training principles 2013 Introduction These principles were developed in 2011 2012 by representatives and members of the following organisations: Sexual Health and Family Planning Australia (SHFPA)
Termination of pregnancy. A resource for health professionals. November 2005. Excellence in women s health
Termination of pregnancy A resource for health professionals November 2005 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists Excellence in women s health This is a publication
Patient information leaflet for Termination of Pregnancy (TOP) / Abortion
Patient information leaflet for Termination of Pregnancy (TOP) / Abortion Families Division Options available If you d like a large print, audio, Braille or a translated version of this leaflet then please
Causes and Consequences of Unintended Pregnancy in Developing Countries
Causes and Consequences of Unintended Pregnancy in Developing Countries Ian Askew, PhD Director, Reproductive Health Services and Research and Co-Director, Strengthening Evidence for Programming on Unintended
Interrupted Pregnancy Coding
Interrupted Pregnancy Coding American College of Obstetricians and Gynecologists Terry Tropin, RHIA, CPC, CCS-P, ACS-OB, PCS Content Development Expert, DecisionHealth ACOG Committee on Coding and Nomenclature
WHAT YOU SHOULD KNOW ABOUT ABORTION
WHAT YOU SHOULD KNOW ABOUT ABORTION It is the public policy of the state of Idaho to prefer live childbirth over abortion: "The Supreme Court of the United States having held that the states have a "profound
Clinical Policy Title: Home uterine activity monitoring
Clinical Policy Title: Home uterine activity monitoring Clinical Policy Number: 12.01.01 Effective Date: August 19, 2015 Initial Review Date: July 17, 2013 Most Recent Review Date: July 15, 2015 Next Review
Antibiotic prophylaxis during obstetric and gynaecology surgery in adults: background information
Antibiotic prophylaxis during obstetric and gynaecology surgery in adults: background information Pages 1 to 3 provide available evidence and references to support the surgical prophylaxis recommendations.
STANDARD APRN PROTOCOL FOR IUD INSERTION: Levonorgestrel (LNG) Releasing Intrauterine System
STANDARD APRN PROTOCOL FOR IUD INSERTION: Levonorgestrel (LNG) Releasing Intrauterine System DEFINITION The LNG-releasing intrauterine systems (Mirena, Liletta and Skyla ) are on the market. The LNG-releasing
Misoprostol for Treatment of Incomplete Abortion: An Introductory Guidebook
Misoprostol for Treatment of Incomplete Abortion: An Introductory Guidebook MISOPROSTOL FOR TREATMENT OF INCOMPLETE ABORTION: AN INTRODUCTORY GUIDEBOOK CONTRIBUTORS: JENNIFER BLUM, JILLIAN BYNUM, RASHA
With 1.1 million induced abortions in the United
Original Research Incidence of Emergency Department Visits and Complications After Abortion Ushma D. Upadhyay, PhD, MPH, Sheila Desai, MPH, Vera Zlidar, MHS, Tracy A. Weitz, PhD, MPA, Daniel Grossman,
South Dakota Task Force to Study Abortion Pierre, South Dakota September 21, 2005
South Dakota Task Force to Study Abortion Pierre, South Dakota September 21, 2005 Section III. : The review and exposition of the body of medical, psychological, and sociological knowledge that has accumulated
WHAT YOU SHOULD KNOW ABOUT ABORTION
WHAT YOU SHOULD KNOW ABOUT ABORTION It is the public policy of the state of Idaho to prefer live childbirth over abortion: "The Supreme Court of the United States having held that the states have a "profound
MHRI IUD Protocol. Migraine with aura Current DVT or PE History of or current breast cancer Active viral hepatitis Severe cirrhosis or liver tumors
Table of Contents A. Indications B. Contraindications C. Prior to Insertion D. Insertion E. Follow-Up Visit F. Removal G. Re-Insertion H. Complications/Side Effects I. Appendices MHRI IUD Protocol A. Indications
the abortion pill by David Hager, M.D.
the abortion pill by David Hager, M.D. A positive pregnancy test is one of the most life-changing moments for a woman. Never is it more important to base your decisions on accurate information. Try to
Traci L. Baird, MPH Susan K. Flinn, MA
Traci L. Baird, MPH Susan K. Flinn, MA Ipas Ipas works globally to improve women s lives through a focus on reproductive health. We train and equip health care providers to ensure that abortion services
AT&T Global Network Client for Windows Product Support Matrix January 29, 2015
AT&T Global Network Client for Windows Product Support Matrix January 29, 2015 Product Support Matrix Following is the Product Support Matrix for the AT&T Global Network Client. See the AT&T Global Network
Comparison of oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion
Indian J Med Res 122, August 2005, pp 132-136 Comparison of oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion Suneeta Mittal, Sonika Agarwal,
bpas.ie I just wanted to say thank you. Your staff showed both kindness and professionalism and this definitely helped me get through the day...
I just wanted to say thank you. Your staff showed both kindness and professionalism and this definitely helped me get through the day... bpas client bpas provides balanced counselling for unplanned pregnancy
Rural Health Advisory Committee s Rural Obstetric Services Work Group
Rural Health Advisory Committee s Rural Obstetric Services Work Group March 15 th webinar topic: Rural Obstetric Patient and Community Issues Audio: 888-742-5095, conference code 6054760826 Rural Obstetric
Quick Start a LARC: Contraception initiation and pregnancy test follow up
Quick Start a LARC: Contraception initiation and pregnancy test follow up Suzanne Pearson, Christina Inness, Mandy Johnson, Kathleen McNamee LARC long acting reversible contraception Implant 3 years IUD
Best practice in comprehensive abortion care
Best practice in comprehensive abortion care Best Practice Paper No. 2 June 2015 Published by the Royal College of Obstetricians and Gynaecologists, 27 Sussex Place, Regent s Park, London NW1 4RG www.rcog.org.uk
RISK EVALUATION AND MITIGATION STRATEGY (REMS) Single Shared System for Mycophenolate
Initial REMS Approval: 09/25/2012 Most Recent Modification: 09/2013 RISK EVALUATION AND MITIGATION STRATEGY (REMS) Single Shared System for Mycophenolate I. GOALS The goals of the Mycophenolate REMS are:
abortion abortion abortion abortion abortion abortion abortion on abortio abortion ortion abortion abortion abortion abortion abortio
Abortion Your questions answered abortio bortion ion ortion on abortio 2 Are you pregnant but not sure you want to have the baby? Do you need more information about your pregnancy choices? Unplanned pregnancy
MEDICAL abortion is the use of pills to
www.rhm-elsevier.com A 2005 Reproductive Health Matters. All rights reserved. Reproductive Health Matters 2005;13(26):20 24 0968-8080/05 $ see front matter PII: S0968-8080(05)26212-2 FEATURES Medical Abortion:
OBSTETRICAL POLICY. Page
OBSTETRICAL POLICY REIMBURSEMENT POLICY Policy Number: ADMINISTRATIVE 200.14 T0 Effective Date: April 1, 2016 Table of Contents APPLICABLE LINES OF BUSINESS/PRODUCTS... APPLICATION... OVERVIEW... REIMBURSEMENT
Women s Health Victoria
Women s Health Victoria Termination of Pregnancy Post 20 Weeks Background Paper March 2007 Prepared by Kerrilie Rice Policy and Research Officer Published by Level 1, 123 Lonsdale Street Melbourne Victoria
Unwanted Pregnancies in the Philippines: the Route to Induced Abortion and health consequences ABSTRACT
Unwanted Pregnancies in the Philippines: the Route to Induced Abortion and health consequences Fatima Juarez, Josefina Cabigon and Susheela Singh JUSTIFICATION ABSTRACT Illegal or clandestine abortion
Medical termination of pregnancy and subsequent adoption of contraception
International Journal of Reproduction, Contraception, Obstetrics and Gynecology Shankaraiah RH et al. Int J Reprod Contracept Obstet Gynecol. 2013 Sep;2(3):367-371 www.ijrcog.org pissn 2320-1770 eissn
Infection after medical abortion: a review of the literature
Contraception 70 (2004) 183 190 Review article Infection after medical abortion: a review of the literature Caitlin Shannon, L. Perry Brothers, Neena M. Philip, Beverly Winikoff* Gynuity Health Projects,
Annotated Bibliography on Misoprostol Alone for Early Abortion
Annotated Bibliography on Misoprostol Alone for Early Abortion 1. Carbonell JL, Rodriguez J, Velazco A, Tanda R, Sanchez C, Barambio S, Chami S, Valero F, Mari J, de Vargas F, Salvador I. Oral and vaginal
This Protocol is adapted from the University of Colorado Protocol dated August 26, 2009.
Protocol for Post-Placental IUD insertion July 14, 2010 This Protocol is adapted from the University of Colorado Protocol dated August 26, 2009. Background Post-placental intrauterine device (IUD) insertion
OBGYN Orientation & Billing Guide 9/22/2014
OBGYN Orientation & Billing Guide 2014 Welcome to Magnolia Health! We thank you for being part of or considering Magnolia s network of participating providers, hospitals, and other healthcare professionals.
Department of Veterans Affairs VHA HANDBOOK 1330.03. Washington, DC 20420 October 5, 2012 MATERNITY HEALTH CARE AND COORDINATION
Department of Veterans Affairs VHA HANDBOOK 1330.03 Veterans Health Administration Transmittal Sheet Washington, DC 20420 October 5, 2012 MATERNITY HEALTH CARE AND COORDINATION 1. REASON FOR ISSUE. This
Medical criteria for IUCD s Based on the WHO MEC (2004- Annexure 3) system a woman s eligibility for IUCD insertion falls in 4 categories. These categ
CLIENT ASSESSMENT Ensure that the woman is not pregnant Determine the length and direction of uterus. Ensure that she does not have gonorrhea and chlamydia, and is not a high risk case of STI s Identify
Thapaliya Kailash et al. Int. Res. J. Pharm. 2015, 6 (6) INTERNATIONAL RESEARCH JOURNAL OF PHARMACY
INTERNATIONAL RESEARCH JOURNAL OF PHARMACY www.irjponline.com ISSN 2230 8407 Research Article USE OF MIFEPRISTONE AND MISOPROSTOL COMBINATION ON ABORTION IN FIRST TRIMESTER PREGNANCY AT GOVERNMENT HOSPITAL
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) CHARTERED BANK ADMINISTERED INTEREST RATES - PRIME BUSINESS*
COMPARISON OF FIXED & VARIABLE RATES (25 YEARS) 2 Fixed Rates Variable Rates FIXED RATES OF THE PAST 25 YEARS AVERAGE RESIDENTIAL MORTGAGE LENDING RATE - 5 YEAR* (Per cent) Year Jan Feb Mar Apr May Jun
